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Synchronous and metachronous thoracic
aneurysms in patients with abdominal aortic
aneurysms
Rabih A. Chaer, MD, Rogerio Vasoncelos, MD, Luke K. Marone, MD, George Al-Khoury, MD,
Robert Y. Rhee, MD, Jae S. Cho, MD, and Michel S. Makaroun, MD, Pittsburgh, Pa
Objective: Although the association of thoracic aortic aneurysm (TAA) with abdominal aortic aneurysm (AAA) is known,
the exact magnitude of the association has not been described. Our goal was to quantify the incidence of TAA in patients
with an AAA and assess predictive factors for its diagnosis.
Methods: This was a retrospective review of all patients diagnosed with AAA from 2000-2008. The subsequent
development or diagnosis of a TAA was noted and the association between AAA and TAA described.
Results: A total of 2196 patients with an AAA were reviewed. 1082 (49.3%) had a chest computed tomography (CT)
during follow-up. 117 patients (10.8%) had a synchronous and 136 (12.6%) a metachronous TAA. Mean time to
diagnosis was 2.3 years. Mean diameter was 4.7  1.4 cm for AAA, and 4.7  1.0 for TAA. Indications for the chest CT
were variable. Most commonwere AAA (15%), pulmonary embolus (14%), and lung cancer (11%). Only 38% of AAAs and
14% of TAAs were repaired during the study period. Of all patients with known AAA who were found to have a TAA,
61/253 (24%) underwent repair, had a rupture, or had a TAA>5.5 cm. At a mean follow-up of 43.6 months, there were
79 deaths (7%): 7 AAA-related and 13 from TAA ruptures. Predictors of TAA diagnosis by logistic regression include
African American race (odds ratio [OR] 1.8; P .02), family history of TAA (OR 7.6; P .04), hypertension (OR
1.7; P  .006), and obesity (OR  1.7; P  .006). Diabetes, infrarenal AAA location, and smoking have a negative
association.
Conclusions: TAAs are relatively common in patients with AAA. Routine or targeted screening with a chest CT at the time
of AAA diagnosis may be indicated. (J Vasc Surg 2012;56:1261-5.)
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aAortic aneurysms disease continues to represent a sig-
nificant cause of mortality in the United States of America,
accounting for up to 16,000 deaths annually.1-3 The infra-
renal abdominal aorta is the most common site of aortic
aneurysm formation, followed by the thoracic aorta.1 The
prevalence of abdominal aortic aneurysm (AAA) is 9% in
patients older than 65 years of age, and the incidence of
thoracic aortic aneurysm (TAA) is at 5.9 to 10.4 patients
per 100,000 persons-years.4-7
The association between AAA and aneurysms of the
popliteal and femoral arteries has been well described,8 and
screening for peripheral aneurysm is currently recom-
mended in patients diagnosed with an AAA. On the other
hand, the prevalence of TAA in patients diagnosed with an
AAA remains poorly characterized,4 despite a well-described
risk of late remote aortic segment events in patients previ-
ously treated for an AAA or a TAA.9-11
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http://dx.doi.org/10.1016/j.jvs.2012.04.056Genetic and environmental factors are also thought to
ontribute to a combined pathophysiology of TAA and
AA.1 Nevertheless, while screening for AAA is currently
ecommended for patients older than 65 with a positive
amily history,12,13 the exact association with TAA remains
nknown and perhaps underappreciated. Current guide-
ines for thoracic aortic screening are limited to small case
eries and expert opinion. Since the predisposing factors for
oth AAA and TAA may overalp,1 and late aortic events in
atients with known aortic aneurysm result in significant
orbidity and mortality, we sought to determine the mag-
itude of this association to potentially support screening
ecommendations for the thoracic aorta in patients diag-
osed with an AAA.
ETHODS
Following approval by the Institutional Review Board
t the University of Pittsburgh, all patients diagnosed with
n AAA between 2000 and 2008 were retrospectively iden-
ified via a programmed search of the electronic medical
ecord (EMR). The EMR system in use includes a wide
earchable database by diagnoses and radiology reports,
ith data input from several hospital systems with auto-
ated daily updates.
Demographic information and details on comorbidities
ere obtained. Anatomic details pertaining to the AAA
ere also obtained, and imaging was reviewed when avail-
ble. The date of first diagnosis of an AAA regardless of the
ize was used as time zero for future TAA events calcula-
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November 20121262 Chaer et altions. Patients with a known TAA but no known AAA were
not included in this analysis.
Data on aneurysm anatomy and treatment were ob-
tained from radiology and operative reports or by direct
review when available and included size, location, and time
interval to TAA detection, as well as treatment strategies
after AAA diagnosis. The EMR query allowed the identifi-
cation of patients with the diagnosis of AAA/TAA. Indi-
vidual charts were then reviewed to determine anatomic
details and the indications for imaging.
Chest imaging in patients diagnosed with an AAA was
not routinely performed but was often available if it had
been obtained for nonaneurysm-related purposes. The date
and findings of the first available chest computed tomogra-
phy (CT), magnetic resonance imaging, or magnetic reso-
nance angiogram of the chest were recorded and reviewed,
and the indication for chest imaging was also noted. All
subsequent chest CT scans or magnetic resonance images
were also reviewed for the development or progression of
an existing TAA. Chest radiographs were not reviewed for
this study as the goal was to identify all thoracic aneurysmal
degeneration, not only large aneurysms that are more likely
to be recognized on simple radiograph.
For descriptive purposes only, we have arbitrarily con-
sidered a TAA as synchronous if diagnosed within 2 years
from the diagnosis of an AAA. All TAAs diagnosed at a later
date were considered metachronous and must have had
prior chest imaging that did not show the presence of TAA.
The aorta was considered aneurysmal when a focal
dilatation of at least 50% larger than the expected normal
adjacent diameter was noted. When images were not
available for review, a reported abdominal aortic diameter
of 3 cm or greater was considered an aneurysm, and a
reported thoracic aortic diameter of3 cm was considered
an aneurysm.
An AAA was considered small when the minor axis
diameter was 5.0 cm in size. Similarly, a TAA was con-
sidered small when the minor axis diameter was5.5 cm in
size.
The designation of TAA included all aneurysm of the
thoracic aorta only (including ascending and arch aneu-
rysms), whereas type IV thoracoabdominal aneurysms were
included with the AAA group since they can be identified
on abdominal imaging. Patients with the mega-aortic syn-
drome with diffuse aortic degeneration, patients with col-
lagen vascular disease, patients who initially presented with
a TAA, patients with aortic dissection, and patients with a
thoracoabdominal aneurysm, including thoracic extension,
were excluded from this series.
Patient records were followed for aneurysm-related
events. Aneurysm presentation such as incidental diagnosis
or rupture was noted. Size progression and follow-up mo-
dalities were also reviewed.
All statistical analyses were performed by an indepen-
dent statistician. Descriptive statistics were performed: the
Wilcoxon rank-sum test or t-test was used with continuous
variables, and 2or Fisher exact test for count data (propor-
tions). Variables associated with TAA among all patients dith AAA were determined with logistic regression. Model
ssumptions were examined and met using Hosmer-
emenshow goodness of fit. The predictionmodel for TAA
ncluded different variables, including age, AAA diameter,
ace, medical comorbidities, family history, and location of
AA (infrarenal vs all others).
Significance was determined at P .05, and all analyses
ere performed using SAS v. 9.2 (SAS Institute Inc, Cary,
C).
ESULTS
Patient population. A total of 2196 patients with
AA disease were identified. Of these, 49.3% (1082 pa-
ients) had a CT scan of the chest available for review of the
horacic aortic anatomy and are the subject of this report.
atients with no thoracic aortic imaging or no known
istory of TAA were excluded from the analysis. The diag-
osis of an AAA was most commonly made by CT scan
75%) or ultrasound (21%).
The mean age at diagnosis of patients with an AAA
as 75  9 years, with a majority of white (91%) male
77%) patients. African American race accounted for 8%
f the patient population. Medical comorbidities are
etailed in the Table and included a high prevalence of
ypertension (75%).
Chest imaging with a CT scan had been performed for
variety of indications, mostly nonaneurysm related, most
ommonly for pulmonary indications (74%) (lung cancer,
ung nodule, pleural effusion, pneumonia, obstructive lung
isease, lung metastases, pulmonary embolus). Chest
creening for patients with a known AAA accounted for
nly 15% of the indications, and miscellaneous indications
or 11%.
Aneurysm anatomy. Out of 1082 patients with a
nown AAA who had a CT scan of the chest, a total of 253
atients (23%) were diagnosed with a TAA: 117 patients
10.8%) had a synchronous and 136 (12.6%) a metachro-
ous TAA. Of all patients with known AAA who were
ound to have a TAA, 61/253 (24%) underwent repair, had
rupture, or had a TAA 5.5 cm.
The mean time to TAA diagnosis was 2.3 years, but
anged from 0 to 107 months. The mean AAA diameter at
iagnosis was 4.7  1.4 cm. The majority of AAAs were
nfrarenal in location (91%), and others were juxtarenal
4%) or type IV thoracoabdominal (5%). Most were small
nd were initially treated conservatively with observation
nd surveillance (62%). The rest were repaired via endovas-
ular repair (21%) or open repair (17%). The mean TAA
iameter at the time of diagnosis was 4.7 1.0 cm. Patients
ith a thoracic aneurysm component were more likely to
ave a suprarenal or juxtarenal aortic aneurysm (23% vs 5%;
 .001), whereas patients with no TAA were more likely
o have an infrarenal AAA (95% vs 77%; P  .001). Only
8% of AAAs and 14% of TAAs were repaired during the
tudy period.
Subgroup comparisons. The 1082 patients in this
eries with a known AAA and with chest CT scans were
ivided into two groups: those with a TAA (n 253, group
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Volume 56, Number 5 Chaer et al 1263I) and those with no TAA (n  829, group II). Patients in
group I were more likely to be older at diagnosis (mean age
76  8.7 vs 74 9; P  .001), with a higher prevalence of
women (42% vs 31%; P .001). African American race was
significantly more common in group I (13% vs 6%; P 
.01). A similar proportion of patients was initially treated
conservatively in both groups (62% vs 60%; P  not signif-
icant [NS]; however, open repair was more commonly used
in group I (25% vs 14%; P  .001). The indications for
chest imaging were also similar among the two groups (P
NS). Diabetes and smoking were common in group II,
whereas hypertension was more common in group I (Table).
Patients in group I were also more likely to have a family
history of aortic aneurysm.
At a mean follow-up of 43.6 months, there were 79
deaths (7%): seven AAA-related and 13 from TAA rupture
(none from dissection). The mean aneurysm diameter at
the time of rupture was 6.0  1.6 cm (median  5.35;
range, 4.2-10.2). Univariate associations of AAA and TAA
are described in the Table.
Associations and predictors of TAA. Predictors of
TAA diagnosis by logistic regression included African
American race (odds ratio [OR]  1.8; P  .02), family
history of TAA (OR 7.6; P .04), hypertension (OR
1.7; P .006), obesity (OR 1.7; P .006), and an AAA
diameter of5 cm on presentation (OR 1.13; P .015).
Using the logistic regression model, the probability for
an African American person to have/develop a TAA 5.5
cm in diameter is 9.4%, and the probability for a person
with hypertension to have/develop a TAA 5.5 cm in
diameter is 3.2%.
Conversely, diabetes (OR  0.5; P  .002), infrarenal
Table. Demographics and univariate associations of AAA
All patients
(n  1082)
A
Mean age (years  SD) 74.6  9.0
Race %
White 90.9
Black 7.9
Hispanic 0.0
Asian 0.3
Other 0.9
Female % 33.1
AAA location %
Juxtarenal 4.1
Infrarenal 90.7
Suprarenal 5.3
Family Hx AAA % 3.0
Family Hx TAA % 0.5
Comorbidities (%)
DM 19.0
HTN 74.5
High cholesterol 43.7
COPD 36.8
Smoking 77.7
Obese 18.6
AAA, Abdominal aortic aneurysms; COPD, chronic obstructive pulmonary
aortic aneurysm.AAA location (vs pararenal or type IV thoracoabdominal) tOR  0.17; P  .001), and surprisingly a history of
urrent or previous smoking (OR  0.7; P  .047) ap-
eared to have a protective effect against the development
f TAA.
Gender, lung disease, coronary artery disease, hypercho-
esterolemia, and lipid lowering therapy were not significant
redictors of TAA in patients with an AAA (PNS).
ISCUSSION
The association between AAA and peripheral arterial
neurysms has been well described. It has been reported
hat in the presence of an AAA, the incidence of a popliteal
neurysm can be as high as 62%, and the incidence of
emoral aneurysms is even higher and can reach 85%.8
Several reports have attempted to describe the associa-
ion between AAA and TAA. Most involve reporting the
revalence of AAA in patients previously treated for a
horacoabdominal or thoracic aneurysm. Expectedly, an
AA may be apparent in up to one half of patients with
horacoabdominal aneurysm repair,9 and a recent meta-
nalysis reported that a total of 12.4% of patients with thoracic
ortic aneurysms and 18.7% of patients with thoracoabdomi-
al aortic aneurysms have had prior AAA surgery.4
Similarly, there are a few small case series in the litera-
ure documenting the association between prior AAA re-
air and the future development of a TAA. However, the
ncidence and prevalence of TAA in patients diagnosed
ith an AAA or followed for a small AAA and the natural
istory of TAA remain largely unknown.4
The pathogenesis of AAA is linked to the interaction of
enetic factors and environmental factors, such as hyper-
AA
ithout TAA
 829)
AAA with TAA
(n  253) P value
.1  9.0 76.3  8.7 .001
.01
92.4 86.2
6.4 12.6
0.0 0.0
0.2 0.4
1.0 0.8
30.5 41.5 .001
.001
2.8 8.3
94.8 77.1
2.4 14.6
2.2 5.9 .002
0.2 1.6 .03
21.1 12.2 .002
72.3 81.8 .002
43.4 44.7 .71
36.1 39.1 .38
79.2 72.7 .03
17.4 22.5 .07
e; DM, diabetes mellitus; HTN, hypertension; Hx, history; TAA, thoracicand T
AA w
(n
74
diseasension, smoking, high cholesterol, and diabetes mellitus.1
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November 20121264 Chaer et alSeveral mechanisms in the pathogenesis of aortic aneu-
rysm have been a reported but are not fully understood.
Aneurysm formation has been associated with lysis of elas-
tin and collagen in the aorticmedia, thus weakening the vessel
wall.3 In addition, matrix metalloproteinases (MMPs) consti-
tute a group of remodeling enzymes, responsible, in part, for
aneurysm disease. MMP-2 cleaves collagen type I (which
constitutes 60% of the content of the aorta). MMP-2
increases with age in patients with TAA and with athero-
sclerotic TAA.3 Similarly, it has been demonstrated that
abdominal aortic aneurysms smaller than 5.5 cm had an
increased MMP-2 activity compared with larger AAAs sug-
gesting that early AAA progress is determined byMMP-2.7
MMP-9 levels are also increased in TAA with or without
atherosclerosis and within AAA wall and appear to be
responsible for accelerated AAA growth.3
Although regional heterogeneity of the aortic wall has
been reported, particular overlap in histochemical changes
are observed in patients with AAA and TAA and may
therefore constitute a common cellular link that explains a
similar pathogenesis. This could potentially translate into a
higher risk of future aneurysmal degeneration of intact
aortic segments and reinforces the perceived association
between AAA and TAA.
Similar to histochemical observations, clinical risk fac-
tors thought to contribute to the pathogenesis of aortic
aneurysm can form the grounds for an association with
TAAs. These include demographics and clinical character-
istics such as age, smoking, hypertension, diabetes, chronic
obstructive pulmonary disease, bodymass index, and family
history that are known to be risk factors for aortic aneurysm
development.
The effect of smoking is surprisingly protective against
thoracic aneurysm formation in the current study but is
likely attributed to confounding. It should be interpreted
with caution given the unequal prevalence of smoking
between the subgroups being compared, the lack of pro-
spective follow-up, and the small sample size and the po-
tential for a type II error.
It has also been demonstrated that hypertensive pa-
tients with prior AAA repair have 4.7% risk of developing a
new aneurysm in 5 years and 18.1% risk in 10 years.10
Consequently, it has been suggested that a more liberal use
of CT scan screening in hypertensive patients who had prior
AAA repair or are being followed for a small aneurysm may
prove to be necessary, secondary to the risk of fatal rupture
and future TAA.10 Similar findings were noted in our series
as we identified hypertension to be a significant predictor of
TAA formation in patients with an AAA.
The impact and association of TAA in patients with an
AAA has been reported in several reports. In a review of
1510 patients treated for aortic aneurysm at all levels,
multiple aortic aneurysms were observed in 12.6% of pa-
tients.5 In addition, Plate et al10 described that the thoracic
aorta was the most frequent aortic site for the development
of a new aneurysm after AAA repair, and the incidence of a
second aneurysm is believed to impact both early and late
survival in patients treated for multiple aortic aneurysms.11 oAortic surveillance may be therefore considered in pa-
ients presenting with any aortic aneurysm, regardless of
ocation. More specifically, the current data seem to define
high-risk population that might benefit from thoracic
ortic screening. This includes patients with an AAA of
frican American race and patients also presenting with
ypertension, obesity, a family history of TAA, or a large
AA (5 cm).
The association of AAA and TAA has been previously
eported but is likely underestimated because of the lack of
ystematic chest imaging. Rupture mortality is very high in
oth the abdominal and thoracic locations, and several
atients in our series and others10 succumbed to TAA
upture. Moreover, almost a quarter of all patients with an
AA in our series were found to have a thoracic aneurysm.
iven this significant association and the consequences of a
issed diagnosis, it appears that full aortic imaging may be
ndicated in patients diagnosed with an AAA.
Additionally, 12.6% of patients with an AAA developed
metachronous aneurysm, suggesting a role for future full
ortic surveillance. Although the thoracic surveillance in-
erval is not well established, it appears that imaging with a
oncontrast chest CT every 3 to 5 years after the initial
creen may be reasonable in line with current guidelines.14
his seems to be particularly important and perhaps most
ost-effective for the high-risk categories defined in this
tudy, such as patients with a family history of TAA, African
merican race, obese or hypertensive patients, and patients
ith a large AAA on presentation.
This study has several limitations inherent to its retro-
pective design. Only 49.3% of patients had chest imaging
or our review, and this may introduce a type II error.
lthough a cohort study may be better suited for a natural
istory disease evaluation, the cost and required lengthy
ollow-up may be prohibitive. The cost-effectiveness of a
horacic screening strategy is also not known and will
esult in an extra charge for the additional chest imaging
omponent.
Nevertheless, there are currently no accepted standard
ecommendations for imaging of the thoracic aorta in
atients followed or treated for an AAA. However, screen-
ng for AAA is currently advocated for all men aged 60 to
5 with risk factors, all women 60 to 85 years of age with
ardiovascular risk factors, and bothmen and women above
0 years of age with family history of AAA.13 In addition,
he U.S. Preventive Task Force reports that screening
ight reduce AAA mortality by 43% in men aged 65 to 70
ears.12 Our study reinforces the need for targeted thoracic
ortic screening in patients with AAA, and prospective data
ollection as part of a systematic aortic screening and sur-
eillance protocol may allow better data acquisition and
efinition of incidence timelines and relationship between
AA and TAA.
ONCLUSIONS
TAAs are relatively common in patients with AAA.
outine or targeted screening with a chest CT at the time
f AAA diagnosis may be indicated. This will allow the
11
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1
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Volume 56, Number 5 Chaer et al 1265definition of the natural history of the disease and the
development of screening and surveillance guidelines that
will hopefully minimize the morbidity and mortality of late
aortic events.
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